Virus-like particle could lead to new cancer vaccine

(Michigan State University) Michigan State University scientists are engineering a virus-like particle, known as Qβ, that will generate anti-cancer immune responses in the body and potentially be used as a new vaccine for the treatment of cancer. The project, funded by a $2.4 million grant from the National Cancer Institute, will support the development of the vaccine to protect animals against cancerous cells that are currently untreatable, and could easily translate to vaccines for humans' us...